BNP Paribas Upgrades Amentum Holdings to Neutral, Lowers Price Target to $20
BNP Paribas analyst Matthew Akers upgrades Amentum Holdings (NYSE:AMTM) from Underperform to Neutral and lowers the price target from $21 to $20.
Stocks · News reference
Amentum Joint Venture Selected As Preferred Supplier By Sellafield Ltd For Up To $2.78B Asset Care And Asset Creation Program
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Amentum Holdings, Inc. (AMTM)
Filed: 2026-10-02 AccNo: 0002011286-26-000026 Size: 5 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Can BWXT's Canadian Lab Role Strengthen Nuclear Services Growth?
BWX Technologies (BWXT) has expanded its nuclear services footprint by beginning management and operations of Canada's National Laboratory through a joint venture in December 2025. The Kinectrics acquisition completed in May 2025 strengthens BWXT's nuclear lifecycle management and isotope production capabilities. Commercial Operations revenues surged 62.8% to $853.1 million in 2025, with consolidated revenues reaching $3.2 billion. BWXT trades at a valuation discount compared to industry peers.